Carina N.

Carina N. is a seasoned venture capitalist and entrepreneur currently serving as a Partner at Plural, an early-stage investment fund focused on impactful technology-driven ventures. Carina co-founded HelixNano, an AI-driven biotech company specializing in next-generation mRNA therapies, and has held several significant board positions, including Board Trustee at The Alan Turing Institute and Board Member roles at Robin AI, Sano Genetics, Omnipresent, Phasecraft, MediShout, and Auquan. Additionally, Carina was a General Partner at Episode 1 Ventures until 2022. Carina's educational background includes degrees from the University of Oxford and Y Combinator.